Luu Brendan

Insider profile

Performance

Overall performance
2.5

Performance over holding periods
2.5
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 65% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Luu Brendan's trades of Enanta Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-12-05 2025-12-05 S Sale
6,497 +23.3%
97.95
US$2,520,076
6,497 +23.3% 97.95 US$2,520,076
2024-12-10 2024-12-06 S Sale
40,955 +46.0%
359.84
US$3,741,024
40,955 +46.0% 359.84 US$3,741,024
2023-12-06 2023-12-05 S Sale
48,529 +39.8%
11.16
US$4,131,731
48,529 +39.8% 11.16 US$4,131,731